Angiotensin converting enzyme inhibition partially prevents deficits in water maze performance, hippocampal synaptic plasticity and cerebral blood flow in streptozotocin-diabetic rats

Brain Research

Volumn 966, Issue 2, 2003, Pages 274-282

  Manschot, Sanne M ^a   Biessels, Geert Jan ^a   Cameron, Norman E ^b   Cotter, Mary A ^b   Kamal, Amer ^a   Kappelle, L Jaap ^a   Gispen, Willem Hendrik ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Angiotensin converting enzyme; Cerebral blood flow; Cerebral dysfunction; Diabetic rat; Enalapril; Hippocampal plasticity; Morris water maze; Streptozotocin

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TESTING ALTERNATIVE; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN DYSFUNCTION; BRAIN PERFUSION; CONTROLLED STUDY; DIABETES MELLITUS; EXPERIMENTAL TEST; HIPPOCAMPUS; HYDROGEN CLEARANCE; LONG TERM POTENTIATION; MALE; MAZE TEST; MEASUREMENT; MICROELECTRODE; NERVE CELL PLASTICITY; NONHUMAN; POLAROGRAPHY; PREVENTION; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; TASK PERFORMANCE; THALAMUS; VASCULAR DISEASE; VASCULARIZATION;

EID: 0037459810     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)04211-7     Document Type: Article

References (48)

1. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the Hope study and Micro-Hope substudy. Heart Outcomes Prevention Evaluation Study Investigators [see comments. Lancet. 355:2000;253-259.
2. Bentsen N., Larsen B., Lassen N.A. Chronically impaired autoregulation of cerebral blood flow in long-term diabetics. Stroke. 6:1975;497-502.
3. Biessels G.J., Cristino N.A., Rutten G.J., Hamers F.P., Erkelens D.W., Gispen W.H. Neurophysiological changes in the central and peripheral nervous system of streptozotocin-diabetic rats. Course of development and effects of insulin treatment. Brain. 122:1999;757-768.
4. Biessels G.J., Kamal A., Ramakers G.M., Urban I.J., Spruijt B.M., Erkelens D.W., Gispen W.H. Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes. 45:1996;1259-1266.
5. Biessels G.J., Kamal A., Urban I.J., Spruijt B.M., Erkelens D.W., Gispen W.H. Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment. Brain Res. 800:1998;125-135.
6. Biessels G.J., Kappelle A.C., Bravenboer B., Erkelens D.W., Gispen W.H. Cerebral function in diabetes mellitus. Diabetologia. 37:1994;643-650.
7. Blezer E.L., Nicolay K., Bar D., Goldschmeding R., Jansen G.H., Koomans H.A., Joles J.A. Enalapril prevents imminent and reduces manifest cerebral edema in stroke-prone hypertensive rats. Stroke. 29:1998;1671-1677.
8. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 361:1993;31-39.
9. Cameron N.E., Cotter M.A. The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diabet. Metab. Rev. 10:1994;189-224.
10. Cameron N.E., Cotter M.A., Robertson S. Angiotensin converting enzyme inhibition prevents development of muscle and nerve dysfunction and stimulates angiogenesis in streptozotocin-diabetic rats. Diabetologia. 35:1992;12-18.
11. Cameron N.E., Dines K.C., Cotter M.A. The potential contribution of endothelin-1 to neurovascular abnormalities in streptozotocin-diabetic rats. Diabetologia. 37:1994;1209-1215.
12. Chabot C., Massicotte G., Milot M., Trudeau F., Gagne J. Impaired modulation of AMPA receptors by calcium-dependent processes in streptozotocin-induced diabetic rats. Brain Res. 768:1997;249-256.
13. 2 clearance curves used to measure blood flow in rat sciatic nerve. J. Physiol. (Lond.). 414:1989;35-54.
14. Di Mario U., Morano S., Valle E., Pozzessere G. Electrophysiological alterations of the central nervous system in diabetes mellitus. Diabetes Metab. Rev. 11:1995;259-277.
15. Duckrow R.B., Beard D.C., Brennan R.W. Regional cerebral blood flow decreases during chronic and acute hyperglycemia. Stroke. 18:1987;52-58.
16. Flood J.F., Morley J.E. Dose-response differences in the ability of ramipril to improve retention in diabetic mice. Eur. J. Pharmacol. 240:1993;311-314.
17. Gispen W.H., Biessels G.J. Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci. 23:2000;542-549.
18. Goa K.L., Haria M., Wilde M.I. Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus. Drugs. 53:1997;1081-1105.
19. Griffith D.N., Saimbi S., Lewis C., Tolfree S., Betteridge D.J. Abnormal cerebrovascular carbon dioxide reactivity in people with diabetes. Diabet. Med. 4:1987;217-220.
20. Grill V., Gutniak M., Bjorkman O., Lindqvist M., Stone-Elander S., Seitz R.J., Blomqvist G., Reichard P., Widen L. Cerebral blood flow and substrate utilization in insulin-treated diabetic subjects. Am. J. Physiol. 258:1990;E813-E820.
21. 125I]Sar1, Ile8-angiotensin II to move between the blood and cerebrospinal fluid compartments. J. Neurochem. 50:1988;554-557.
22. Harik S.I., LaManna J.C. Vascular perfusion and blood-brain glucose transport in acute and chronic hyperglycemia. J. Neurochem. 51:1988;1924-1929.
23. Heiss W.D., Traupe H. Comparison between hydrogen clearance and microsphere technique for rCBF measurement. Stroke. 12:1981;161-167.
24. Jakobsen J., Nedergaard M., Aarslew Jensen M., Diemer N.H. Regional brain glucose metabolism and blood flow in streptozocin-induced diabetic rats. Diabetes. 39:1990;437-440.
25. Jakobsen J., Sidenius P., Gundersen H.J., Osterby R. Quantitative changes of cerebral neocortical structure in insulin-treated long-term streptozocin-induced diabetes in rats. Diabetes. 36:1987;597-601.
26. Jouquey S., Mathieu M.N., Hamon G., Chevillard C. Effect of chronic treatment with trandolapril or enalapril on brain ACE activity in spontaneously hypertensive rats. Neuropharmacology. 34:1995;1689-1692.
27. Kamal A., Biessels G.J., Urban I.J., Gispen W.H. Hippocampal synaptic plasticity in streptozotocin-diabetic rats: impairment of long-term potentiation and facilitation of long-term depression. Neuroscience. 90:1999;737-745.
28. Kappelle A.C., Biessels G.J., van Buren T., Erkelens D.W., De Wildt D.J., Gispen W.H. Effects of nimodipine on sciatic nerve blood flow and vasa nervorum responsiveness in the diabetic rat. Eur. J. Pharmacol. 250:1993;43-49.
29. Knudsen G.M., Gobel U., Paulson O.B., Kuschinsky W. Regional density of perfused capillaries and cerebral blood flow in untreated short-term and long-term streptozotocin diabetes. J. Cereb. Blood Flow Metab. 11:1991;361-365.
30. Leibson C.L., Rocca W.A., Hanson V.A., Cha R., Kokmen E., O'Brien P.C., Palumbo P.J. Risk of dementia among persons with diabetes mellitus:a population-based cohort study. Am. J. Epidemiol. 145:1997;301-308.
31. Low P.A., Lagerlund T.D., McManis P.G. Nerve blood flow and oxygen delivery in normal, diabetic, and ischemic neuropathy. Int. Rev. Neurobiol. 31:1989;355-438.
32. Malenka R.C. Synaptic plasticity in the hippocampus: LTP and LTD. Cell. 78:1994;535-538.
33. Malik R.A., Williamson S., Abbott C., Carrington A.L., Iqbal J., Schady W., Boulton A.J. Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial [see comments]. Lancet. 352:1998;1978-1981.
34. Mankovsky B.N., Metzger B.E., Molitch M.E., Biller J. Cerebrovascular disorders in patients with diabetes mellitus. J. Diabetes Complications. 10:1996;228-242.
35. Mayhan W.G., Simmons L.K., Sharpe G.M. Mechanism of impaired responses of cerebral arterioles during diabetes mellitus. Am. J. Physiol. 260:1991;H319-H326.
36. McCuskey P.A., McCuskey R.S. In vivo and electron microscopic study of the development of cerebral diabetic microangiography. Microcirc. Endothel. Lymphat. 1:1984;221-244.
37. Morris R.G., Garrud P., Rawlins J.N., O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature. 297:1982;681-683.
38. Ott A., Stolk R.P., Hofman A., Van Harskamp F., Grobbee D.E., Breteler M.M.B. Association of diabetes mellitus and dementia: The Rotterdam study. Diabetologia. 39:1996;1392-1397.
39. Pelligrino D.A., Albrecht R.F. Chronic hyperglycemic diabetes in the rat is associated with a selective impairment of cerebral vasodilatory responses. J. Cereb. Blood Flow Metab. 11:1991;667-677.
40. Printz M.P. Regulation of the brain angiotensin system: a thesis of multicellular involvement. Clin. Exp. Hypertens. A. 10:1988;17-35.
41. Ramakers G.M., Urban I.J., de Graan P.N., Di Luca M., Cattabeni F., Gispen W.H. The impaired long-term potentiation in the CA1 field of the hippocampus of cognitive deficient microencephalic rats is restored by D-serine. Neuroscience. 54:1993;49-60.
42. O2 in diabetic rats. Am. J. Physiol. 249:1985;H540-H546.
43. Simpson R.E. 3, Phillis J.W., Buchannan J. A comparison of cerebral blood flow during basal, hypotensive, hypoxic and hypercapnic conditions between normal and streptozotocin diabetic rats. Brain Res. 531:1990;136-142.
44. Skarphedinsson J.O., Harding H., Thoren P. Repeated measurements of cerebral blood flow in rats. Comparisons between the hydrogen clearance method and laser Doppler flowmetry. Acta Physiol. Scand. 134:1988;133-142.
45. Stewart R., Liolitsa D. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet. Med. 16:1999;93-112.
46. Sutera S.P., Chang K., Marvel J., Williamson J.R. Concurrent increases in regional hematocrit and blood flow in diabetic rats: prevention by sorbinil. Am. J. Physiol. 263:1992;H945-H950.
47. 125I]angiotensin II to the circumventricular organs. Neuroscience. 10:1983;1421-1426.
48. Wright J.W., Harding J.W. Regulatory role of brain angiotensins in the control of physiological and behavioral responses. Brain Res. Brain Res. Rev. 17:1992;227-262.